Author:
Bingham Clifton O.,Looney R. John,Deodhar Atul,Halsey Neal,Greenwald Maria,Codding Christine,Trzaskoma Benjamin,Martin Flavius,Agarwal Sunil,Kelman Ariella
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference40 articles.
1. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004
2. Rituximab for rheumatoid arthritis refractory to antiâtumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006
3. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial;Emery;Arthritis Rheum,2006
4. Characterization of a human B lymphocyte-specific antigen;Stashenko;J Immunol,1980
5. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis;Keystone;Arthritis Rheum,2007
Cited by
397 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献